Impact of TECAR Therapy on Pain and Function in Adhesive Capsulitis: a Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Visual Analogue Scale (VAS) for pain
研究概览
简要总结
Transfer Energy Capacitive and Resistive (TECAR) therapy is a heat therapy method that increases blood circulation at the microscopic level by generating heat in the upper and lower layers of your tissues, reduces inflammation and supports tissue regeneration. In this study, we aimed to evaluate whether this treatment reduces pain and improves functioning in patients with frozen shoulder disease.
详细描述
Adhesive capsulitis (AC), commonly known as "frozen shoulder," is a prevalent and painful condition resulting from the contracture of the glenohumeral capsule, which significantly impacts individuals' quality of life. While AC is self-limiting in many cases, some patients may experience long-term functional limitations if not treated promptly. One promising intervention is transfer energy capacitive and resistive (TECAR) therapy, which has gained attention for its potential to enhance tissue regeneration, reduce inflammation, and improve pain management by generating heat in superficial and deep tissues. This study aimed to evaluate the effects of TECAR therapy on pain and functional outcomes in patients with adhesive capsulitis (AC).
This prospective, randomized controlled clinical trial included 60 patients [TECAR group: 30, (50.37 ± 13.90 years); control group: 30, (55.27 ± 10.44 years)]. Both groups completed a 2-week tailored therapeutic exercise program, with 30-minute hot pack application and Transcutaneous Electrical Nerve Stimulation. The TECAR group also received three TECAR therapy sessions per week, for a total of six sessions. Pain was measured using the Visual Analog Scale (VAS), functional status with the Shoulder Pain and Disability Index (SPADI), and supraspinatus tendon thickness and bicipital effusion were assessed via ultrasonography. Evaluations were conducted at baseline, 1 and 3 months post-treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 67 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who were than 18 years of age
- •Patients with unilateral shoulder pain of at least 3 on a 10-point Visual Analog Scale (VAS);
- •Patients who experienced a more than 50% loss of passive ROM (abduction or external rotation) in the glenohumeral joint relative to the unaffected side
- •Patients who had been experiencing the related symptoms for ≥ 3 months.
排除标准
- •Patients who had previous shoulder surgery
- •Patients who had shoulder injection within the last 3 months
- •Patients with inflammatory rheumatic disease,
- •Patients with cervical radiculopathy
- •Pregnant patients
- •Pateints with thyroid disease
- •Patients with malignancy,
- •Patients who had history of cardiac pacemakers,
- •Patients with epilepsy
- •Patients who had neurological disease with or without cognitive impairment
结局指标
主要结局
Visual Analogue Scale (VAS) for pain
时间窗: VAS for pain was applied to the patients before the procedure and at the 4th week and the 12th week after the procedure.
The Visual Analog Scale (VAS) was employed to evaluate pain intensity in patients. This scale features a 10 cm horizontal line, where one end represents "no pain" (0) and the other represents "worst imaginable pain" (10). Patients were instructed to place a mark on the line that best reflected their current pain level. The distance from the "no pain" end to the patient's mark was measured in centimeters and recorded as the VAS score, providing a numeric representation of their pain intensity
次要结局
- Shoulder Pain and Disability Index (SPADI)(SPADI) was applied to the patients before the procedure and at the 4th week and 12th week after the procedure.)
研究者
Oznur Uzun
MD, Deputy Chief of Physical Medicine and Rehabilitation Hospital, Principal Investigator
Ankara City Hospital Bilkent